Warren, NJ, United States of America

Jeffrey Donald Hermes

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 1998-2013

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Jeffrey Donald Hermes

Introduction

Jeffrey Donald Hermes is a notable inventor based in Warren, NJ (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of five patents, focusing primarily on the development of beta-lactamase inhibitors. His work has significant implications for the treatment of bacterial infections, particularly those resistant to conventional antibiotics.

Latest Patents

Hermes' latest patents include innovative compounds that serve as beta-lactamase inhibitors. One of his notable inventions involves substituted bicyclic beta-lactams, which are designed to combat bacterial infections in conjunction with beta-lactam antibiotics. These compounds are particularly effective against microorganisms that have developed resistance due to the presence of beta-lactamases. Another significant patent features novel beta-lactamase inhibitors from the aryl- and heteroaryl-sulfonamidomethylphosphonate monoester class. These compounds not only inhibit three classes of beta-lactamases but also enhance the antibacterial effects of beta-lactam antibiotics against resistant microorganisms.

Career Highlights

Throughout his career, Jeffrey Donald Hermes has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Hermes has collaborated with several professionals in his field, including notable coworkers such as Helen Y Chen and Seongkon Kim. These collaborations have likely enriched his research and development efforts, leading to significant advancements in antibiotic therapies.

Conclusion

Jeffrey Donald Hermes is a distinguished inventor whose work on beta-lactamase inhibitors has the potential to transform the treatment of bacterial infections. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…